Ingrid Zerbe
Secrétaire Général chez INTELGENX TECHNOLOGIES CORP.
Fortune : 975 858 $ au 30/04/2024
Profil
Ingrid Zerbe is the founder and director of Intelgenx Corp., which was founded in 2003.
She is currently working as a secretary at IntelGenx Technologies Corp.
since 2006.
In terms of education, she has an undergraduate degree from the University of Dortmund.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/03/2023 | 5 158 221 ( inf% ) | 861 423 $ | 30/04/2024 | |
| 29/01/2024 | 685 238 ( 0,39% ) | 114 435 $ | 30/04/2024 |
Postes actifs de Ingrid Zerbe
| Sociétés | Poste | Début |
|---|---|---|
| INTELGENX TECHNOLOGIES CORP. | Secrétaire Général | 01/04/2006 |
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Fondateur | 12/10/2010 |
Formation de Ingrid Zerbe
| University of Dortmund | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTELGENX TECHNOLOGIES CORP. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
